Anhui Anke Biotechnology (Group) Co., Ltd. (SHE:300009)
China flag China · Delayed Price · Currency is CNY
7.63
-0.07 (-0.91%)
Nov 17, 2026, 3:04 PM CST

SHE:300009 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Cash & Equivalents
179.91250.2299.18260.23324.59322.56
Short-Term Investments
105.99141.07----
Trading Asset Securities
1,1441,1921,1451,196842.91805.43
Cash & Short-Term Investments
1,4301,5831,4441,4561,1671,128
Cash Growth
9.13%9.65%-0.82%24.70%3.50%26.10%
Accounts Receivable
423.21495.56492.35597.44476.3543.89
Other Receivables
134.7435.1630.54911.2546.96
Receivables
557.95530.73522.9606.44487.55590.85
Inventory
311.25252.75297.3235.22210.48181.25
Other Current Assets
42.0128.3611.0328.0345.0221.53
Total Current Assets
2,3412,3952,2752,3251,9111,922
Property, Plant & Equipment
1,5811,6251,5841,4341,176881.34
Long-Term Investments
405.41789.28515.54404.38347.89188.09
Goodwill
66.5666.5666.5666.5657.657.6
Other Intangible Assets
379.47393.66412.32450.36275.64126.22
Long-Term Deferred Tax Assets
88.0361.541.829.5341.851.22
Long-Term Deferred Charges
225.61204.8223.28223.8413.28386.18
Other Long-Term Assets
60.4412.1517.1517.134.4156.81
Total Assets
5,1485,5485,1354,9514,2573,669

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Accounts Payable
184.85252.28215.02211.7151.01141.11
Accrued Expenses
73.71255.35238.6328.25240.6306.76
Short-Term Debt
50.03-5-3-
Current Portion of Leases
7.757.6610.718.816.083.3
Current Income Taxes Payable
62.2256.3958.2243.9146.8893.12
Current Unearned Revenue
17.988.0919.3424.4327.9619.51
Other Current Liabilities
159.2659.93120.69229.98200.2762.99
Total Current Liabilities
555.79639.7667.59847.08675.8626.79
Long-Term Leases
17.8325.2938.2547.8224.0623.74
Long-Term Unearned Revenue
126.19123.43121.53113.52114.16107.18
Long-Term Deferred Tax Liabilities
7.0720.578.0510.0141.147.81
Other Long-Term Liabilities
2.312.31----
Total Liabilities
709.2811.3835.411,018855.17765.52

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Common Stock
1,6711,6731,6731,6771,6731,638
Additional Paid-In Capital
461.37459.5508.66519.82405.73186.87
Retained Earnings
2,4282,3762,0581,7671,337961.26
Treasury Stock
-2.14-14.55-114.57-226.22-207.41-
Comprehensive Income & Other
-177.5764.76----
Total Common Equity
4,3804,5584,1243,7373,2092,787
Minority Interest
59.14178.34175.63194.93193.09116.97
Shareholders' Equity
4,4394,7364,3003,9323,4022,904
Total Liabilities & Equity
5,1485,5485,1354,9514,2573,669

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Total Debt
75.6132.9653.9656.6333.1427.04
Net Cash (Debt)
1,3541,5501,3901,3991,1341,101
Net Cash Growth
5.84%11.54%-0.66%23.35%3.03%25.04%
Net Cash Per Share
0.810.930.830.840.690.69
Filing Date Shares Outstanding
1,6901,6661,6781,6611,5891,638
Total Common Shares Outstanding
1,6901,6661,6781,6611,5891,638
Working Capital
1,7851,7551,6081,4781,2351,295
Book Value Per Share
2.592.742.462.252.021.70
Tangible Book Value
3,9344,0983,6453,2202,8752,603
Tangible Book Value Per Share
2.332.462.171.941.811.59
Buildings
-767.14545.04583.06564.87469.79
Machinery
-809.14760.51624.66562.37528.17
Construction In Progress
-620.77799.75672.51445.68228.75